2-Fluoro-3-(trifluoromethyl)benzylamine, 97.0%, 1g

3-BROMO-4-(TRIFLUOROMETHYL)BENZYLAMINE, 95.0%, 250mg

3-(2H-1,2,3-Triazol-4-yl)benzonitrile, 95.0%, 5g

2,4-Bis(4-(tert-butyl)phenyl)-6-chloro-1,3,5-triazine, 98%, 100mg

Obiettivo Plan PLPH 20x/0,40 per contrasto di fase

Diethylmethylsilane, 90%, 5g

(1H-Benzo[d]imidazol-2-yl)methanamine dihydrochloride, 95.0%, 1g

Acido 4-azidobenzoico, minimo 97%, 10 mg, confezione in plastica.

1-(3-Hydroxypropyl)-2-pyrrolidone>96.0%(GC)10mL

2-Bromo-5-fluorobenzonitrile>97.0%(GC)25g

3-(thiophen-2-yl)-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 1g

4,7,8-Trichloroquinoline, 98%, 1g

6-chloro-3-ethyl[1,2,4]triazolo[4,3-b]pyridazine, 95.0%, 250mg